The First Approved Gene Therapy Product for Cancer Ad-p53(Gendicine): 12 Years in the Clinic-Reference-Cited by-同舟云学术

The First Approved Gene Therapy Product for Cancer Ad-p53(Gendicine): 12 Years in the Clinic

Published:2018-02 Issue:2 Volume:29 Page:160-179
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Zhang Wei-Wei¹²,Li Longjiang³,Li Dinggang⁴,Liu Jiliang⁵,Li Xiuqin⁶,Li Wei⁷,Xu Xiaolong⁷,Zhang Michael J.⁸,Chandler Lois A.²,Lin Hong⁷,Hu Aiguo⁷,Xu Wei⁷,Lam Dominic Man-Kit¹

Affiliation:

1. LifeTech Biosciences Group, Hong Kong.

2. Angionetics, Inc., San Diego, California.

3. State Key Laboratory of Oral Disease, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

4. Beijing Haidian Hospital Center for Cancer Gene Therapy, Beijing, China.

5. Shenzhen Hengsheng Hospital Cancer Center, Shenzhen, China.

6. China Medical University Shengjing Hospital Department of Obstetrics and Gynecology, Shenyang, China.

7. Shenzhen SiBiono GeneTech Co. Ltd., Shenzhen, China.

8. Department of Medicine University of Minnesota Medical School, Minneapolis, Minnesota.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2017.218

Reference190 articles.

1. Gendicine: The First Commercial Gene Therapy Product; Chinese Translation of Editorial

2. Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers

3. Gene therapy clinical trials worldwide to 2012 - an update

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects;Current Gene Therapy;2024-10

2. Locally advanced and metastatic endometrial cancer: Current and emerging therapies;Cancer Treatment Reviews;2024-09

3. Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy;Current Gene Therapy;2024-08

4. p53 at the crossroads of tumor immunity;Nature Cancer;2024-07-15

5. Time course of fluorescent-labelled oligonucleotide accumulation in cells with the use of folate receptor-targeted cationic liposomes;Biological Products. Prevention, Diagnosis, Treatment;2024-06-03